Phase 1b study of andecaliximab (GS-5745, ADX) as monotherapy and in combination with nivolumab (nivo) in Japanese subjects with gastric or GEJ adenocarcinoma.-MedSci.cn

Phase 1b study of andecaliximab (GS-5745, ADX) as monotherapy and in combination with nivolumab (nivo) in Japanese subjects with gastric or GEJ adenocarcinoma.

Yamaguchi, K; Satoh, T; Muro, K; Takashima, A; Ichimura, T; Sakai, D; Kadowaki, S; Chin, K; Kudo, T; Mitani, S; Kitano, S; Bhargava, P; Zavodovskaya, M; Liu, J; Fukui, M; Boku, N

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (4):

科室
- - 订阅+
  - 更多科室
工具
服务